Autologous dendritoma vaccineAlternative Names: Melaxin
Latest Information Update: 16 Feb 2010
At a glance
- Originator Oncolix
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Malignant melanoma